WHO ICTRP trial
microRNA as prognostic and diagnostic markers in malignant melanoma.
DRKS00024417 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00024417 |
|---|---|
| Public title | microRNA as prognostic and diagnostic markers in malignant melanoma. |
| Scientific title | microRNA as prognostic and diagnostic markers in malignant melanoma. |
| Primary sponsor | Universitätsklinikum Halle (Saale) |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | C43.9;Malignant melanoma of skin, unspecified;C43.9 |
| Interventions | Group 1: Peripheral blood serum of patients with malignant melanoma will be collected during routine blood sampling and analyzed with in situ hybridization and quantitative realtime PCR to detect miRNA expression. |
| Registration date | Nov 8, 2021 |
| Target size | 10 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: